Background: AI promises tailored tobacco cessation interventions but landscape is heterogeneous. Methods: Scoping review of PubMed, Scopus, Web of Science, Google Scholar (2000–April 2025) per Arksey common uses — quit prediction, relapse risk, chatbots, automated messaging. Limited evidence on integration into clinical settings, LMIC applicability, equity and privacy reporting. Conclusion: AI holds potential in cessation but requires robust effectiveness, equity and implementation research, especially in LMICs.
Mohanty et al. (Sun,) studied this question.